Cargando…
MRI T1 Contrast-Enhanced Signal Intensity Is a Prognostic Indicator of Imatinib Therapy in Desmoid-Type Fibromatosis
OBJECTIVE: To investigate the efficiency of pre-therapy magnetic resonance imaging (MRI) features in predicting the prognosis of desmoid-type fibromatosis patients treated with imatinib. MATERIALS AND METHODS: A total of 38 desmoid-type fibromatosis patients treated with imatinib were collected in t...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040797/ https://www.ncbi.nlm.nih.gov/pubmed/33854962 http://dx.doi.org/10.3389/fonc.2021.615986 |